Molecular dynamics simulations in drug discovery and pharmaceutical development

OMH Salo-Ahen, I Alanko, R Bhadane, AMJJ Bonvin… - Processes, 2020 - mdpi.com
Molecular dynamics (MD) simulations have become increasingly useful in the modern drug
development process. In this review, we give a broad overview of the current application …

Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals

AM Healy, ZA Worku, D Kumar, AM Madi - Advanced drug delivery reviews, 2017 - Elsevier
Active pharmaceutical ingredients (APIs) may exist in various solid forms, which can lead to
differences in the intermolecular interactions, affecting the internal energy and enthalpy, and …

Recent advances in co-amorphous drug formulations

SJ Dengale, H Grohganz, T Rades… - Advanced drug delivery …, 2016 - Elsevier
Co-amorphous drug delivery systems have recently gained considerable interest in the
pharmaceutical field because of their potential to improve oral bioavailability of poorly water …

Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations

A Paudel, ZA Worku, J Meeus, S Guns… - International journal of …, 2013 - Elsevier
Spray drying is an efficient technology for solid dispersion manufacturing since it allows
extreme rapid solvent evaporation leading to fast transformation of an API-carrier solution to …

Co-amorphous solid dispersions for solubility and absorption improvement of drugs: Composition, preparation, characterization and formulations for oral delivery

A Karagianni, K Kachrimanis, I Nikolakakis - Pharmaceutics, 2018 - mdpi.com
The amorphous solid state offers an improved apparent solubility and dissolution rate.
However, due to thermodynamic instability and recrystallization tendencies during …

Emerging trends in the stabilization of amorphous drugs

R Laitinen, K Löbmann, CJ Strachan… - International journal of …, 2013 - Elsevier
The number of active pharmaceutical substances having high therapeutic potential but low
water solubility is constantly increasing, making it difficult to formulate these compounds as …

Engineering cocrystals of poorly water-soluble drugs to enhance dissolution in aqueous medium

I Sathisaran, SV Dalvi - Pharmaceutics, 2018 - mdpi.com
Biopharmaceutics Classification System (BCS) Class II and IV drugs suffer from poor
aqueous solubility and hence low bioavailability. Most of these drugs are hydrophobic and …

Use of pharmaceutical salts and cocrystals to address the issue of poor solubility

DP Elder, R Holm, HL De Diego - International journal of pharmaceutics, 2013 - Elsevier
Salt and cocrystal formation are the most commonly used method of increasing solubility
and dissolution rate of pharmaceutical compounds, and are of particular interest for …

[HTML][HTML] Advances in coamorphous drug delivery systems

Q Shi, SM Moinuddin, T Cai - Acta pharmaceutica sinica B, 2019 - Elsevier
In recent years, the coamorphous drug delivery system has been established as a promising
formulation approach for delivering poorly water-soluble drugs. The coamorphous solid is a …

Amino acids as co-amorphous stabilizers for poorly water soluble drugs–Part 1: Preparation, stability and dissolution enhancement

K Löbmann, H Grohganz, R Laitinen, C Strachan… - European journal of …, 2013 - Elsevier
Poor aqueous solubility of an active pharmaceutical ingredient (API) is one of the most
pressing problems in pharmaceutical research and development because up to 90% of new …